Nguyen Dinh Thanh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nguyen Dinh Thanh has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Vu Ngoc Toan
Institute of New Technology, Academy of Military Science and Technology, Ministry of Defence, 17 Hoang Sam, Nghia Do, Ha Noi, Viet Nam
34 shared publicationsHoang Thi Kim Van
Faculty of Chemistry, Viet Tri University of Industry, 9 Tien Son, Thanh Mieu, Phu Tho, Viet Nam
27 shared publicationsDo Son Hai
Faculty of Chemistry, VNU University of Science (Vietnam National University, Ha Noi), 19 Le Thanh Tong, Hoan Kiem, Ha Noi 10000, Viet Nam
20 shared publicationsNguyen Thi Kim Giang
Faculty of Chemistry VNU University of Science (Vietnam Nation University) Hanoi Vietnam
19 shared publicationsDuong Ngoc Toan
Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Phan Dinh Phung, Thai Nguyen, Viet Nam
18 shared publicationsNguyen Minh Tri
Institute of New Technology, Academy of Military Science and Technology, Ministry of Defence, 17 Hoang Sam, Nghia Do, Ha Noi, Viet Nam
18 shared publications
Latest Publications
- 25 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (5) , 2644-2666
d -Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling
D -Galactose–pyrimidine thioureas were synthesized via a recyclable ionic liquid–microwave method in high yields. Several derivatives showed broad-spectrum antimicrobial activity, and docking with ADMET predicted strong binding and drug-like properties.
- 25 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (5) , 2644-2666
d -Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling
D -Galactose–pyrimidine thioureas were synthesized via a recyclable ionic liquid–microwave method in high yields. Several derivatives showed broad-spectrum antimicrobial activity, and docking with ADMET predicted strong binding and drug-like properties.
- 11 February 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (3) , 670-678
Maltose-Conjugated Thiosemicarbazones from Substituted Benzaldehydes: Synthesis and Inhibitory Activity against Gram-(+) and Gram-(−) Bacteria
The increasing prevalence of multidrug-resistant bacteria necessitates the development of new antibacterial scaffolds with improved efficacy and safety. Thiosemicarbazones are known for their diverse antibacterial activities, and carbohydrate conjugation can enhance solubility and biocompatibility. In this study, a series of β-maltosyl thiosemicarbazones of substituted benzaldehydes (6a-u) were synthesized and evaluated for their antibacterial activity against representative Gram-(+) and Gram-(-) bacterial strains. These compounds displayed a wide range activity range with MIC of 0.78-400 μg mL-1. Compounds 6b, 6c, 6f, 6i, 6n, 6q, and 6r were the most active, exhibiting MIC values as low as 0.78 μg mL-1 against several pathogens and, in some cases, comparable to ciprofloxacin and vancomycin. Structure-activity relationship analysis revealed a strong dependence on aromatic substitution patterns. Analogues bearing electron-withdrawing substituents (Cl, Br, and NO2) on the benzene ring showed markedly enhanced antibacterial activity, whereas electron-donating substituents (-OH, -OCH3) generally reduced antibacterial activity. Enzyme inhibition assays identified compound 6f as a potent inhibitor of Staphylococcus aureus DNA gyrase and compound 6b as a strong topoisomerase IV inhibitor. Importantly, the most active compounds showed a low cytotoxicity toward WI-38 human fibroblast cells.
- 11 February 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (3) , 670-678
Maltose-Conjugated Thiosemicarbazones from Substituted Benzaldehydes: Synthesis and Inhibitory Activity against Gram-(+) and Gram-(−) Bacteria
The increasing prevalence of multidrug-resistant bacteria necessitates the development of new antibacterial scaffolds with improved efficacy and safety. Thiosemicarbazones are known for their diverse antibacterial activities, and carbohydrate conjugation can enhance solubility and biocompatibility. In this study, a series of β-maltosyl thiosemicarbazones of substituted benzaldehydes (6a-u) were synthesized and evaluated for their antibacterial activity against representative Gram-(+) and Gram-(-) bacterial strains. These compounds displayed a wide range activity range with MIC of 0.78-400 μg mL-1. Compounds 6b, 6c, 6f, 6i, 6n, 6q, and 6r were the most active, exhibiting MIC values as low as 0.78 μg mL-1 against several pathogens and, in some cases, comparable to ciprofloxacin and vancomycin. Structure-activity relationship analysis revealed a strong dependence on aromatic substitution patterns. Analogues bearing electron-withdrawing substituents (Cl, Br, and NO2) on the benzene ring showed markedly enhanced antibacterial activity, whereas electron-donating substituents (-OH, -OCH3) generally reduced antibacterial activity. Enzyme inhibition assays identified compound 6f as a potent inhibitor of Staphylococcus aureus DNA gyrase and compound 6b as a strong topoisomerase IV inhibitor. Importantly, the most active compounds showed a low cytotoxicity toward WI-38 human fibroblast cells.
- 16 October 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (23) , e202500620
Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity
A series of 2‐iminothiazolidin‐4‐one–1,3,4‐thiazole hybrids 7a–l are synthesized and screened for their inhibitory activities against responsible enzymes in type 2 diabetes mellitus (T2DM) and Alzheimer's diseases. Among the compounds with potential inhibitory activity, several 2‐iminothiazolidin‐4‐ones exhibit the strongest inhibitory activity against the screened enzymes, including 7c (IC 50 = 6.12 ± 0.11 µM, for α‐amylase), 7e (IC 50 = 6.78 ± 0.15 µM, for α‐glucosidase), 7k (IC 50 = 1.82 ± 0.04 µM, for DPP‐4), 7f (IC 50 = 2.21 ± 0.02 µM, for PTP1B), 7h (IC 50 = 0.06 ± 0.01 nM, for AChE), 7j (IC 50 = 0.03 ± 0.01 nM, for BChE, and IC 50 = 0.32 ± 0.01 nM, for MAO‐A), and 7l (IC 50 = 0.02 ± 0.01 nM, for MAO‐B). Compound 7j exhibits the strongest inhibitory activity for both BChE and MAO‐A. Compounds with short‐chain alkyl groups (2–4 carbon atoms) have the strongest inhibitory activity against the enzymes responsible in T2DM, with the exception of 7k (with 6‐carbon atom chain), whereas the long‐chain alkyl groups (with 5–7 carbon atom chains) have the strongest inhibitory activity against the enzymes responsible in Alzheimer's disease. These compounds also exhibit the high antiglycation and antioxidant activity in DPPH and ABTS •+ scavenging assays. They are noncytotoxic for WI‐38 cell line with IC 50 > 76 μM.
- 16 October 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (23) , e202500620
Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity
A series of 2‐iminothiazolidin‐4‐one–1,3,4‐thiazole hybrids 7a–l are synthesized and screened for their inhibitory activities against responsible enzymes in type 2 diabetes mellitus (T2DM) and Alzheimer's diseases. Among the compounds with potential inhibitory activity, several 2‐iminothiazolidin‐4‐ones exhibit the strongest inhibitory activity against the screened enzymes, including 7c (IC 50 = 6.12 ± 0.11 µM, for α‐amylase), 7e (IC 50 = 6.78 ± 0.15 µM, for α‐glucosidase), 7k (IC 50 = 1.82 ± 0.04 µM, for DPP‐4), 7f (IC 50 = 2.21 ± 0.02 µM, for PTP1B), 7h (IC 50 = 0.06 ± 0.01 nM, for AChE), 7j (IC 50 = 0.03 ± 0.01 nM, for BChE, and IC 50 = 0.32 ± 0.01 nM, for MAO‐A), and 7l (IC 50 = 0.02 ± 0.01 nM, for MAO‐B). Compound 7j exhibits the strongest inhibitory activity for both BChE and MAO‐A. Compounds with short‐chain alkyl groups (2–4 carbon atoms) have the strongest inhibitory activity against the enzymes responsible in T2DM, with the exception of 7k (with 6‐carbon atom chain), whereas the long‐chain alkyl groups (with 5–7 carbon atom chains) have the strongest inhibitory activity against the enzymes responsible in Alzheimer's disease. These compounds also exhibit the high antiglycation and antioxidant activity in DPPH and ABTS •+ scavenging assays. They are noncytotoxic for WI‐38 cell line with IC 50 > 76 μM.
- 19 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (12) , 6132-6152
Lactose-conjugated 2-iminothiazolidin-4-ones: synthesis, inhibitory activity and molecular simulations as potential inhibitors against enzymes responsible for type 2 diabetes
New lactose–2-iminothiazolidin-4-one hybrids 7a–h had the multi-target inhibitions for T2DM enzymes. They showed high anti-glycation, antioxidant activities and no-cytotoxic for WI-38 cell. Molecular docking and dynamics studies were applied.
- 19 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (12) , 6132-6152
Lactose-conjugated 2-iminothiazolidin-4-ones: synthesis, inhibitory activity and molecular simulations as potential inhibitors against enzymes responsible for type 2 diabetes
New lactose–2-iminothiazolidin-4-one hybrids 7a–h had the multi-target inhibitions for T2DM enzymes. They showed high anti-glycation, antioxidant activities and no-cytotoxic for WI-38 cell. Molecular docking and dynamics studies were applied.
- 19 August 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (37) , 16397-16414
Synthesis, antiproliferative activity, ADMET, molecular docking, molecular dynamics simulation, and DFT study for coumarin-based 1,5-benzothiazepines
Some coumarin–benzothiazepine hybrids 6a–h were synthesized and screened for their anticancer activity against KB and HepG2 cells. Hybrid 6h had IC 50 of 4.0 and 6.25 μM, respectively. Molecular docking, dynamics simulations, and B3LYP/6-311++G(d,p)/DFT were applied for 6b, 6d, 6f, and 6h.
- 19 August 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (37) , 16397-16414
Synthesis, antiproliferative activity, ADMET, molecular docking, molecular dynamics simulation, and DFT study for coumarin-based 1,5-benzothiazepines
Some coumarin–benzothiazepine hybrids 6a–h were synthesized and screened for their anticancer activity against KB and HepG2 cells. Hybrid 6h had IC 50 of 4.0 and 6.25 μM, respectively. Molecular docking, dynamics simulations, and B3LYP/6-311++G(d,p)/DFT were applied for 6b, 6d, 6f, and 6h.
- 23 July 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (7) , e70039
Substituted D ‐Galactose‐Conjugated Thiazole‐Thioureas Derivatives as Promising Antidiabetic Agents: Synthesis, In Vitro Inhibition, and Molecular Simulation for α‐Amylase, α‐Glucosidase, Protein Glycation, and Oxidative Stress
A thiourea series ( 7a–l ) containing 4‐arylthiazoles and the d ‐galactose moiety were synthesized and explored for their multi‐target inhibition against α ‐ amylase from porcine pancreas and α ‐ glucosidase from Saccharomyces cerevisiae . Among these thioureas, 7h was the most potent inhibitor for α‐amylase (IC 50 of 7.84 ± 0.14 μM) and 7c was the most potent inhibitor for α‐glucosidase (IC 50 of 7.15 ± 0.12 μM). These thioureas also exhibited anti‐glycation and antioxidant activity. They were noncytotoxic for NIH‐3T3 cells. Induced‐fit molecular docking study was applied to the two most potential inhibitors 7c and 7h . Their active interactions with residues in the catalytic pockets of the corresponding studied enzymes, 1OSE and 3TOP, were suitable to their inhibitory potentials against each tested enzyme. The molecular dynamics simulations validated the in vitro data for these compounds whereas the pharmacokinetics profile (ADMET) revealed the druglike properties of potent inhibitors.
- 23 July 2025
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (7) , e70039
Substituted D ‐Galactose‐Conjugated Thiazole‐Thioureas Derivatives as Promising Antidiabetic Agents: Synthesis, In Vitro Inhibition, and Molecular Simulation for α‐Amylase, α‐Glucosidase, Protein Glycation, and Oxidative Stress
A thiourea series ( 7a–l ) containing 4‐arylthiazoles and the d ‐galactose moiety were synthesized and explored for their multi‐target inhibition against α ‐ amylase from porcine pancreas and α ‐ glucosidase from Saccharomyces cerevisiae . Among these thioureas, 7h was the most potent inhibitor for α‐amylase (IC 50 of 7.84 ± 0.14 μM) and 7c was the most potent inhibitor for α‐glucosidase (IC 50 of 7.15 ± 0.12 μM). These thioureas also exhibited anti‐glycation and antioxidant activity. They were noncytotoxic for NIH‐3T3 cells. Induced‐fit molecular docking study was applied to the two most potential inhibitors 7c and 7h . Their active interactions with residues in the catalytic pockets of the corresponding studied enzymes, 1OSE and 3TOP, were suitable to their inhibitory potentials against each tested enzyme. The molecular dynamics simulations validated the in vitro data for these compounds whereas the pharmacokinetics profile (ADMET) revealed the druglike properties of potent inhibitors.
- 14 July 2025
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 34 (8) , 1746-1770
Synthesis and inhibitory activity against enzymes responsible for Type 2 diabetes mellitus of lactose-conjugated thiosemicarbazones from substituted acetophenones
- 14 July 2025
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 34 (8) , 1746-1770
Synthesis and inhibitory activity against enzymes responsible for Type 2 diabetes mellitus of lactose-conjugated thiosemicarbazones from substituted acetophenones